Management of Raynaud's phenomenon and digital ulcers in systemic sclerosis

被引:23
|
作者
Botzoris, Vasileios [1 ]
Drosos, Alexandros A. [1 ]
机构
[1] Univ Ioannina, Sch Med, Rheumatol Clin, Dept Internal Med, GR-45110 Ioannina, Greece
关键词
Raynaud's phenomenon; Digital ulcers; Systemic sclerosis; Vasculopathy; Management; CALCIUM-CHANNEL BLOCKERS; RECEPTOR ANTAGONIST BOSENTAN; DOUBLE-BLIND; PHENOMENON SECONDARY; GLYCERYL TRINITRATE; SINGLE-CENTER; SCLERODERMA; THERAPY; INHIBITOR; MULTICENTER;
D O I
10.1016/j.jbspin.2010.11.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Raynaud's phenomenon (RP) and digital ulcers (DU) are the clinical manifestations of vasculopathy in systemic sclerosis. Both interfere with hand function and hold the possibility of severe complications, thus adversely influencing patients' quality of life. Managing RP and DU is often a challenge for the treating physician, who has to establish a treatment plan based upon knowledge of the current therapeutic options. The first step is to differentiate primary from secondary RP, where combining history and physical examination with diagnostic modalities, such as nailfold capillaroscopy, aids in reaching the correct diagnosis. Next a wide range of treatment options is offered nowadays, starting from first-line agents, as calcium channel blockers, to the more targeted-ones, like endothelin receptor antagonists. Research and clinical experience with each agent are reviewed in the text, as well as the combinations that more recently gain field in the treatment of DU. (C) 2010 Societe francaise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:341 / 346
页数:6
相关论文
共 50 条
  • [31] The patient experience of Raynaud's phenomenon in systemic sclerosis
    Pauling, John D.
    Saketkoo, Lesley Ann
    Matucci-Cerinic, Marco
    Ingegnoli, Francesca
    Khanna, Dinesh
    [J]. RHEUMATOLOGY, 2019, 58 (01) : 18 - 26
  • [32] Raynaud's phenomenon and vascular disease in systemic sclerosis
    Generini, S
    Cerinic, MM
    [J]. RHEUMADERM: CURRENT ISSUES IN RHEUMATOLOGY AND DERMATOLOGY, 1999, 455 : 93 - 100
  • [33] HOW TO TREAT RAYNAUD'S PHENOMENON & SYSTEMIC SCLEROSIS?
    Riemekasten, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 4 - 4
  • [34] Digital sympathectomy (microarteriolysis) in the treatment of severe Raynaud's phenomenon secondary to systemic sclerosis
    Hapner, J
    Della Santa, D
    Zuber, C
    Christen, Y
    Bounameaux, H
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1997, 137 (06) : 1019 - 1020
  • [35] Treatment of Raynaud phenomenon and ischemic ulcers associated to systemic sclerosis with hyperbaric oxygen
    Ahijon-Lana, Maria
    Baragano-Ordonez, Elia
    Veiga-Cabello, Raul
    de la Cruz-Tapidor, Carmen
    Carreira, Patricia E.
    [J]. REUMATOLOGIA CLINICA, 2022, 18 (04): : 246 - 248
  • [36] Quantifying digital vascular disease in patients with primary Raynaud's phenomenon and systemic sclerosis
    Herrick, AL
    Clark, S
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1998, 57 (02) : 70 - 78
  • [37] BOSENTAN FOR THE TREATMENT OF ISCHEMIC DIGITAL ULCERS AND RAYNAUD'S PHENOMENON
    Nitsche, Alejandro
    Crow, Catherine E.
    Asnal, Cecilia A.
    Amitrano, Cristina
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S51 - S51
  • [38] Audiovestibular Manifestations in Patients with Primary Raynaud's Phenomenon and Raynaud's Phenomenon Secondary to Systemic Sclerosis
    Carlos Amor-Dorado, Juan
    Martin-Sanz, Eduardo
    Franco-Gutierrez, Virginia
    Urruticoechea-Arana, Ana
    Garcia-Arumi, Ana M.
    Racines-Alava, Erwin
    Aleman-Lopez, Oscar
    Simeon-Aznar, Carmen P.
    Gonzalez-Gay, Miguel A.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (09)
  • [39] Management of Raynaud's Phenomenon and Digital Ischemia
    Herrick, Ariane L.
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2013, 15 (01)
  • [40] Management of Raynaud’s Phenomenon and Digital Ischemia
    Ariane L. Herrick
    [J]. Current Rheumatology Reports, 2013, 15